Veradigm (MDRX) – Major News
-
Allscripts (MDRX) Tops Q3 EPS by 4c
-
Allscripts (MDRX) Misses Q1 EPS by 10c; Affirms Outlook
-
Allscripts (MDRX) Tops Q4 EPS by 54c
-
Allscripts (MDRX) Guides Q4 Revenues Above the Street, Announces $250M Stock Buyback
-
Allscripts (MDRX) Tops Q3 EPS by 9c
-
Allscripts (MDRX) Tops Q2 EPS by 6c
-
Allscripts (MDRX) Tops Q1 EPS by 4c; Provides FY21 Revenues Outlook
-
Allscripts (MDRX) Tops Q4 EPS by 8c
-
Allscripts (MDRX) Tops Q3 EPS by 1c
-
Allscripts (MDRX) Tops Q2 EPS by 6c
-
Allscripts (MDRX) Misses Q1 EPS by 6c, Revenues Miss; Withdraws FY20 Guidance
-
Allscripts (MDRX) Misses Q4 EPS by 1c, Offers Q1 and FY Guidance
-
Allscripts (MDRX) Reports In-Line Q3 EPS
-
Allscripts (MDRX) Tops Q2 EPS by 1c; Raises Bookings Outlook
-
Allscripts (MDRX) Misses Q4 EPS by 1c, FY EPS Guidance Misses
-
Allscripts (MDRX) Misses Q3 EPS by 2c
-
Allscripts (MDRX) Reports In-Line Q2 EPS, Offers Guidance, Approves $250M Buyback
-
Allscripts (MDRX) Misses Q1 EPS by 1c, Affirms Outlook
-
Allscripts (MDRX) Reports In-Line Q4 EPS
-
Allscripts (MDRX) Reports In-Line Q3 EPS
-
Allscripts (MDRX) Reports In-Line Q2 EPS
-
Allscripts (MDRX) Reports In-Line Q1 EPS, Affirms Fy 2017 Outlook
-
Allscripts (MDRX) Misses Q4 EPS by 1c, Offers Guidnce
-
Allscripts (MDRX) Gains After Affirming Q4 Guidance, Offering FY17 Guidance
-
Allscripts (MDRX) Misses Q3 EPS by 1c; Guides Q4 EPS Below Views
-
Allscripts (MDRX) Reports In-Line Q2 EPS
-
Allscripts (MDRX) Tops Q1 EPS by 1c
-
Allscripts (MDRX) Reports In-Line Q4 EPS
-
Allscripts (MDRX) Tops Q3 EPS by 1c
-
Allscripts (MDRX) Tops Q2 EPS by 1c, Affirms FY Guidance
-
Allscripts (MDRX) Prelim. Q2 Results Outpace Expectations
-
Allscripts (MDRX) Misses Q1 EPS by 1c, Lowers FY15 Revenue Guidance
-
Allscripts (MDRX) Reports In-Line Q4 EPS
-
Allscripts (MDRX) Misses Q3 EPS by 4c
-
Allscripts (MDRX) Reports In-Line Q2 EPS
-
Allscripts (MDRX) Reports In-Line Q1 EPS
-
Allscripts (MDRX) Reports In-Line Q4 EPS
-
Allscripts (MDRX) Misses Q3 EPS by 3c
-
Allscripts (MDRX) Misses Q2 EPS by 2c
-
Allscripts (MDRX) Misses Q1 EPS by 5c
-
Allscripts (MDRX) Posts Q4 non-GAAP EPS of 16c
-
Allscripts-Misys (MDRX) Names New CEO, Ends Sales Process With No Deal
-
Allscripts Healthcare Solutions (MDRX) CEO Glen Tullman Steps Down
-
Allscripts (MDRX) Tops Q3 EPS by 5c; Withdrawing Guidance; to Evaluate Alternatives
-
Allscripts (MDRX) said to be exploring possible sale to private equity
-
Allscripts (MDRX) Tops Q2 EPS by 2c
-
Allscripts (MDRX) Misses Q1 EPS by 12c; Lowers FY12 Outlook; 4 Directors, CFO to Leave
-
Allscripts-Misys Healthcare (MDRX) Reports In-Line Q4 EPS; Issues FY12 EPS, Revs Outlook
-
Allscripts-Misys Healthcare Solution (MDRX) Tops Q3 EPS by 2c, Raises FY11 Guidance
-
Allscripts (MDRX) Reports In-Line Q2 EPS; Boosts Bottom-End of FY11 Outlook
Back to MDRX Stock Lookup